Back to Search
MICHELE CANDELORE, D.O.
D.O.
Internal Medicine Physician
NPI: 1720146566IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
OS8236(FL)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE
Class of 1997
Research & Publications (18)
Discovery of potent, orally active benzimidazole glucagon receptor antagonists.
PMID 18539028·Bioorg Med Chem Lett·2008
7-preclinical
Cloning and expression of canine glucagon receptor and its use to evaluate glucagon receptor antagonists in vitro and in vivo.
PMID 17140563·Eur J Pharmacol·2007
7-preclinical
Design and synthesis of conformationally constrained tri-substituted ureas as potent antagonists of the human glucagon receptor.
PMID 17126016·Bioorg Med Chem Lett·2007
7-preclinical
Direct observation (NMR) of the efficacy of glucagon receptor antagonists in murine liver expressing the human glucagon receptor.
PMID 16256355·Bioorg Med Chem·2006
4-observational
Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists.
PMID 16102966·Bioorg Med Chem Lett·2005
7-preclinical
Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptor.
PMID 15713396·Bioorg Med Chem Lett·2005
8-other
Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists.
PMID 15464082·Eur J Pharmacol·2004
4-observational
Phytosphingosine 1-phosphate: a high affinity ligand for the S1P(4)/Edg-6 receptor.
PMID 12270137·Biochem Biophys Res Commun·2002
7-preclinical
Beta(3)-adrenoceptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeys.
PMID 11259557·J Pharmacol Exp Ther·2001
7-preclinical
Human beta3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties.
PMID 11212115·Bioorg Med Chem Lett·2001
4-observational
Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human beta3 adrenergic receptor agonists.
PMID 11055339·Bioorg Med Chem Lett·2000
8-other
Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide.
PMID 11052788·J Med Chem·2000
7-preclinical
L-750355, a human beta3-adrenoceptor agonist; in vitro pharmacology and profile of activity in vivo in the rhesus monkey.
PMID 11050305·Eur J Pharmacol·2000
7-preclinical
Human beta3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides.
PMID 10999482·Bioorg Med Chem Lett·2000
4-observational
Potent, selective 3-pyridylethanolamine beta3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore.
PMID 10987429·Bioorg Med Chem Lett·2000
7-preclinical
Substituted oxazole benzenesulfonamides as potent human beta3 adrenergic receptor agonists.
PMID 10915043·Bioorg Med Chem Lett·2000
7-preclinical
Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agents.
PMID 10888325·Bioorg Med Chem Lett·2000
7-preclinical
Discovery of an orally bioavailable alkyl oxadiazole beta3 adrenergic receptor agonist.
PMID 10888324·Bioorg Med Chem Lett·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 13880 Shell Point Plz Ste 200
Fort Myers, FL 33908 - Phone
- (239) 466-1111
Quick Facts
- NPI
- 1720146566
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 29
- Publications
- 18
Are you this provider?
Claim Your Profile